Literature DB >> 25754197

Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells.

Pablo Ruiz Díaz1, Juan Mucci2, María Ana Meira1, Yanina Bogliotti3, Daniel Musikant4, María Susana Leguizamón5, Oscar Campetella2.   

Abstract

The trans-sialidases (TSs) from Trypanosoma cruzi, the agent of Chagas disease, are virulence factors shed to the bloodstream that induce strong alterations in the immune system. Here, we report that both enzymatically active TS (aTS) and its lectinlike isoform (iTS) disturb CD4 T cell physiology, inducing downregulation of Th1 cell functionality and in vivo cell expansion. By using ovalbumin-specific DO11.10 cells as tracers of clones developing the Th1 phenotype, we found that the infection induced significant amounts of gamma interferon (IFN-γ) but low levels of interleukin 2 (IL-2) and increased IL-4 production in vivo, in agreement with a mixed T helper response. The production of cytokines associated with the Th2 phenotype was prevented by passive transfer of anti-TS neutralizing antibodies. TSs also reduced the T cell receptor signaling as assayed by Zap-70 phosphorylation. TSs also reduced IL-2 and IFN-γ secretion, with a concomitant increase in IL-4 production and then an unbalancing of the CD4 T cell response toward the Th2 phenotype. This effect was prevented by using anti-IL-10 neutralizing antibodies or IL-10(-/-) antigen-presenting cells, supporting the subversion of this regulatory pathway. In support, TSs stimulated IL-10 secretion by antigen-presenting cells during their interaction with CD4 T cells. When polarized cells were stimulated in the presence of TSs, the secretion of IL-2 and IFN-γ was strongly downregulated in Th1 cells, while IL-2 production was upregulated in Th2 cells. Although the Th1 response is associated with host survival, it may simultaneously induce extensive damage to infected tissues. Thus, by delaying the elicitation of the Th1 response and limiting its effector properties, TSs restrain the cell response, supporting T. cruzi colonization and persistence while favoring host survival.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25754197      PMCID: PMC4399057          DOI: 10.1128/IAI.00031-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Enzymically inactive members of the trans-sialidase family from Trypanosoma cruzi display beta-galactose binding activity.

Authors:  M L Cremona; O Campetella; D O Sánchez; A C Frasch
Journal:  Glycobiology       Date:  1999-06       Impact factor: 4.313

2.  Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation.

Authors:  Romina P Muiá; Hai Yu; Jennifer A Prescher; Ulf Hellman; Xi Chen; Carolyn R Bertozzi; Oscar Campetella
Journal:  Glycobiology       Date:  2010-03-30       Impact factor: 4.313

3.  Crystal structure of an enzymatically inactive trans-sialidase-like lectin from Trypanosoma cruzi: the carbohydrate binding mechanism involves residual sialidase activity.

Authors:  Pablo Oppezzo; Gonzalo Obal; Martín A Baraibar; Otto Pritsch; Pedro M Alzari; Alejandro Buschiazzo
Journal:  Biochim Biophys Acta       Date:  2011-04-30

Review 4.  Protection and pathology during parasite infection: IL-10 strikes the balance.

Authors:  S A Redpath; N M Fonseca; G Perona-Wright
Journal:  Parasite Immunol       Date:  2014-06       Impact factor: 2.280

5.  Initial induction of immunity, followed by suppression of responses to parasite antigens during Trypanosoma cruzi infection of mice.

Authors:  R L Tarleton; D W Scott
Journal:  Parasite Immunol       Date:  1987-09       Impact factor: 2.280

6.  The Trypanosoma cruzi immunosuppressive factor (TIF) targets a lymphocyte activation event subsequent to increased intracellular calcium ion concentration and translocation of protein kinase C but previous to cyclin D2 and cdk4 mRNA accumulation.

Authors:  F Kierszenbaum; S Majumder; P Paredes; M K Tanner; M B Sztein
Journal:  Mol Biochem Parasitol       Date:  1998-04-01       Impact factor: 1.759

7.  Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.

Authors:  M P Nunes; R M Andrade; M F Lopes; G A DosReis
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

8.  Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.

Authors:  L C Barbosa de Oliveira; M A Curotto de Lafaille; G M Collet de Araujo Lima; I de Almeida Abrahamsohn
Journal:  Cell Immunol       Date:  1996-05-25       Impact factor: 4.868

9.  IL-10 mediates susceptibility to Trypanosoma cruzi infection.

Authors:  S G Reed; C E Brownell; D M Russo; J S Silva; K H Grabstein; P J Morrissey
Journal:  J Immunol       Date:  1994-10-01       Impact factor: 5.422

10.  The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1).

Authors:  Svenja Steinfelder; John F Andersen; Jennifer L Cannons; Carl G Feng; Manju Joshi; Dennis Dwyer; Pat Caspar; Pamela L Schwartzberg; Alan Sher; Dragana Jankovic
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

View more
  14 in total

Review 1.  The Trypanosoma cruzi Surface, a Nanoscale Patchwork Quilt.

Authors:  Juan Mucci; Andrés B Lantos; Carlos A Buscaglia; María Susana Leguizamón; Oscar Campetella
Journal:  Trends Parasitol       Date:  2016-11-11

Review 2.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

Review 3.  Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.

Authors:  Oscar Campetella; Carlos A Buscaglia; Juan Mucci; María Susana Leguizamón
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-20       Impact factor: 5.187

4.  Sialic acid removal by trans-sialidase modulates MMP-2 activity during Trypanosoma cruzi infection.

Authors:  Daniel Musikant; Romina Higa; Cristina E Rodríguez; Martin M Edreira; Oscar Campetella; Alicia Jawerbaum; María S Leguizamón
Journal:  Biochimie       Date:  2021-04-20       Impact factor: 4.079

Review 5.  Modulation of Cell Sialoglycophenotype: A Stylish Mechanism Adopted by Trypanosoma cruzi to Ensure Its Persistence in the Infected Host.

Authors:  Leonardo Freire-de-Lima; Leonardo M da Fonseca; Vanessa A da Silva; Kelli M da Costa; Alexandre Morrot; Célio G Freire-de-Lima; Jose O Previato; Lucia Mendonça-Previato
Journal:  Front Microbiol       Date:  2016-05-11       Impact factor: 5.640

6.  Sialic Acid Glycobiology Unveils Trypanosoma cruzi Trypomastigote Membrane Physiology.

Authors:  Andrés B Lantos; Giannina Carlevaro; Beatriz Araoz; Pablo Ruiz Diaz; María de Los Milagros Camara; Carlos A Buscaglia; Mariano Bossi; Hai Yu; Xi Chen; Carolyn R Bertozzi; Juan Mucci; Oscar Campetella
Journal:  PLoS Pathog       Date:  2016-04-08       Impact factor: 6.823

7.  Role of Inactive and Active Trypanosoma cruzi Trans-sialidases on T Cell Homing and Secretion of Inflammatory Cytokines.

Authors:  Leonardo Freire-de-Lima; Luciana B Gentile; Leonardo M da Fonseca; Kelli M da Costa; Jessica Santos Lemos; Lucas Rodrigues Jacques; Alexandre Morrot; Célio G Freire-de-Lima; Marise P Nunes; Christina M Takiya; Jose O Previato; Lucia Mendonça-Previato
Journal:  Front Microbiol       Date:  2017-07-11       Impact factor: 5.640

8.  Inactive trans-Sialidase Expression in iTS-null Trypanosoma cruzi Generates Virulent Trypomastigotes.

Authors:  Carla A Pascuale; Juan M Burgos; Miriam Postan; Andrés B Lantos; Adriano Bertelli; Oscar Campetella; M Susana Leguizamón
Journal:  Front Cell Infect Microbiol       Date:  2017-10-04       Impact factor: 5.293

9.  Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype.

Authors:  Estefanía Prochetto; Carolina Roldán; Iván A Bontempi; Daiana Bertona; Luz Peverengo; Miguel H Vicco; Luz M Rodeles; Ana R Pérez; Iván S Marcipar; Gabriel Cabrera
Journal:  Oncotarget       Date:  2017-05-25

Review 10.  The Mitogen-Activated Protein Kinase (MAPK) Pathway: Role in Immune Evasion by Trypanosomatids.

Authors:  Mercedes Soares-Silva; Flavia F Diniz; Gabriela N Gomes; Diana Bahia
Journal:  Front Microbiol       Date:  2016-02-24       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.